Trial Profile
Active Immunotherapy of Patients With Acute Myeloid Leukemia Using Autologous Dendritic Cells Transfected With RNA Encoding Leukemia-associated Antigens
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dendritic cell vaccines-Medigene Immnotherapies (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Proof of concept
- 10 Oct 2018 Status changed from discontinued to completed.
- 24 Mar 2018 Status changed from suspended to discontinued.
- 09 Sep 2017 Results (n=13) presented at the 3rd CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.